MetaCap

ACADIA Pharmaceuticals (ACAD) News

NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.11-0.48 (-2.73%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ACAD news summary

We found 11 recent headlines mentioning ACADIA Pharmaceuticals (ACAD): 1 in the past week and 5 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ACAD is down 2.73% at $17.11. The most recent story, "Acadia Expands Rett Syndrome Partnership In Japan Through KYORIN Agreement", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ACADIA Pharmaceuticals headlines

Stocks mentioned alongside ACAD

Compare ACAD